Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,055,568 papers from all fields of science
Search
Sign In
Create Free Account
Naphthyridines
Known as:
Naphthyridines [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
Narrower (45)
1,5-naphthyridinone oxabicyclooctane
1-methoxy-canthin-6-one
2,7-diamido-1,8-naphthyridine
2,7-diamino-1,8-naphthyridine
Expand
In Blood
agonists
antagonists & inhibitors
chemical synthesis
Broader (1)
naphthyridine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Base-Mediated Hydroamination of Alkynes.
M. Patel
,
Rakesh K. Saunthwal
,
A. Verma
Accounts of Chemical Research
2017
Corpus ID: 5899971
Inter- or intramolecular hydroamination reactions are a paradigmatic example of modern sustainable organic chemistry, as they are…
Expand
2014
2014
Naphthyridines as Novel BET Family Bromodomain Inhibitors
O. Mirguet
,
Yann Lamotte
,
+11 authors
E. Nicodème
ChemMedChem
2014
Corpus ID: 20377365
Bromodomains (BRDs) are small protein domains found in a variety of proteins that recognize and bind to acetylated histone tails…
Expand
Highly Cited
2012
Highly Cited
2012
Copper-catalyzed tandem synthesis of indolo-, pyrrolo[2,1-a]isoquinolines, naphthyridines and bisindolo/pyrrolo[2,1-a]isoquinolines via hydroamination of ortho-haloarylalkynes followed by C-2…
A. Verma
,
R. R. Jha
,
R. Chaudhary
,
R. Tiwari
,
K. S. Reddy
,
Abhinandan K. Danodia
Journal of Organic Chemistry
2012
Corpus ID: 35933261
An efficient approach for the copper-catalyzed regioselective tandem synthesis of diversely substituted indolo[2,1-a…
Expand
2010
2010
Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).
W. Engen
,
T. E. O’Brien
,
+5 authors
Marc O. Anderson
Bioorganic & Medicinal Chemistry
2010
Corpus ID: 1258692
2009
2009
Selection and analysis of HIV-1 integrase strand transfer inhibitor resistant mutant viruses.
M. Witmer
,
R. Danovich
Methods
2009
Corpus ID: 41108989
Review
2007
Review
2007
Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives.
S. Srivastava
,
A. Jha
,
S. Agarwal
,
R. Mukherjee
,
A. Burman
Anti-Cancer Agents in Medicinal Chemistry
2007
Corpus ID: 2066198
The disease of cancer has been ranked second after cardiovascular diseases and plant-derived molecules have played an important…
Expand
Highly Cited
2002
Highly Cited
2002
Synthesis of substituted isoquinolines by electrophilic cyclization of iminoalkynes.
Qinhua Huang
,
J. A. Hunter
,
R. Larock
Journal of Organic Chemistry
2002
Corpus ID: 20261007
The tert-butylimines of o-(1-alkynyl)benzaldehydes and analogous pyridinecarbaldehydes have been cyclized under very mild…
Expand
Highly Cited
2001
Highly Cited
2001
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures.
Perry S. Corbin
,
S. Zimmerman
,
P. Thiessen
,
N. Hawryluk
,
T. J. Murray
Journal of the American Chemical Society
2001
Corpus ID: 26019916
The synthesis and conformational studies of heterocyclic ureas (amides) 1-7 and their concentration-dependent unfolding to form…
Expand
2000
2000
Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors.
L. Chan
,
T. Stefanac
,
+5 authors
H. Jin
Bioorganic & Medicinal Chemistry Letters
2000
Corpus ID: 36378695
1999
1999
Fluorescent 2,7-Dialkylamino-[1,8]-Naphthyridines: Preparation and Spectroscopic Properties
C. Hoock
,
J. Reichert
,
M. Schmidtke
1999
Corpus ID: 17764308
Substitution of 4-methyl-[1,8]-naphthyridine in 2 and 7 position by alkylamines leads to highly fluorescent compounds. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE